Skip to content
Business Company News, Defence

Amaero Commissions Second Advanced Atomizer in the U.S. On Schedule

Jane Morgan Management 2 mins read

Sydney, Australia – Amaero Ltd (ASX:3DA, OTC:AMROF) (“Amaero” or “the Company”) has successfully commissioned its second advanced Electrode Induction Melting Inert Gas Atomizer (EIGA Premium) at its flagship facility in Tennessee, marking a major milestone in the company’s manufacturing scale-up.

The new EIGA Premium unit is only the second of its kind to be commissioned in the U.S. and the third globally, reinforcing Amaero’s position as a leader in high-performance alloy powder production for defense, aerospace, and advanced manufacturing sectors.

Amaero Chairman and CEO Hank J. Holland said the investment was part of a broader $72 million capital program to enhance domestic production capacity and deliver on growing demand.

“Amaero acted decisively and committed to invest A$72 million in capital expenditures to  improve the flagship Tennessee manufacturing facility and to commission the largest U.S. domestic capacity production for refractory and titanium alloy spherical powders. The Company’s forward-leaning capital investments position Amaero with a completed manufacturing facility and with production capacity that’s available to meet a surge in demand for U.S. manufacturing. The capability and capacity provide Amaero with an important first-mover advantage, resulting in a more resilient, more scalable and more responsive U.S. domestic supply chain for the defense industrial base and the broader advanced manufacturing ecosystem.

 

As we move into FY2026, Amaero will be focused on scaling production and delivering commercial contracts and agreements. We are pleased to go into the fiscal year with strong visibility of revenue due to strategic long-term agreements with Castheon/KAM/ADDMAN and Velo3D, as well as a cornerstone purchase order for 27 tonnes of titanium spherical powder to be shipped in 1H FY2026,” added Mr Holland.


The Tennessee facility’s A$28 million upgrade is on track for substantial completion by the end of June 2025. A third atomizer, ordered in December 2024, is scheduled for commissioning in June 2026.

Amaero also reaffirmed its revenue guidance, with approximately 80% of forecast revenue for Q1 and Q2 FY2026 already visible, supported by long-term agreements and from received purchase orders, including a major 27-tonne titanium powder order due for shipment in 1H FY2026.


Key Facts:

Jane Morgan
Director
P: +61 405 555 618
[email protected]


About us:

About Amaero Ltd
Amaero Ltd (ASX:3DA, OTC:AMROF) is an ASX-listed and OTC-listed company with manufacturing and corporate headquarters located in Tennessee, U.S. Amaero is a leading U.S. domestic producer of high-value refractory and titanium alloy spherical powders for additive and advanced manufacturing of components utilised by the defense, space, aviation, industrial and medical industries with manufacturing and corporate headquarters located in Tennessee. The technical and manufacturing team brings decades of experience and know-how with pioneering work in gas atomization of refractory and titanium alloys. The Company has commissioned advanced gas atomization technology with an industry leading yield of AM powder. The Company is also a leader in PM-HIP (Powder Metallurgy Hot Isostatic Pressing) manufacturing of large, near-net-shape powder parts with forged-equivalent material properties and microstructure for a variety of alloys. PM-HIP manufacturing is helping alleviate the strained domestic supply chain for large scale castings and forgings.

Media

More from this category

  • Business Company News
  • 08/07/2025
  • 15:28
CPA Australia

RBA interest rates decision adds pressure to government’s productivity roundtable

8 July 2025 RBA interest rates decision adds pressure to government’s productivity roundtable SMEs continue to navigate uncertain economic waters Government’s focus on productivity…

  • Contains:
  • Business Company News, Medical Health Aged Care
  • 08/07/2025
  • 11:08
Nova Eye Medical (ASX:EYE)

Nova Eye Medical Delivers Record Revenues for FY25

HIGHLIGHTS Record revenues of A$28.8m for the year ended 30 June 2025 and in line with guidance Six consecutive half-years of growth in the USA with H2FY25 US sales up 25% onpcp Q4FY25 sales of A$8.4m the highest on record Nova Eye Medical Limited (ASX: EYE) (Nova Eye or the Company) is pleased to report a record sales result for FY25. Group revenue for FY25 reached A$28.8 million (US$18.4 million), up 21% (in constant currency) from FY24. Key drivers include: US sales of US$14.2 million, up 25% withiTrack™ Advance delivering six consecutive half-years of revenue growth. H2FY25 sales A$15.7 million…

  • Business Company News, Manufacturing
  • 08/07/2025
  • 10:38
Jane Morgan Management

Amaero Unlocks Velo3D Supply Agreement with Powder Certification from Auburn’s NCAME

Sydney, Australia – Amaero Ltd (ASX:3DA, OTC: AMROF) (“Amaero” or “the Company”) has entered into a strategic collaboration with Auburn University’s National Center for Additive Manufacturing Excellence (NCAME) to accelerate development and testing of its proprietary C103 and Ti64 alloy powders. The collaboration has already delivered key milestones. NCAME has verified that Amaero’s powders meet key aerospace and additive manufacturing standards, including ASTM F3635 for C103 and AMS7015/ASTM F3001 for Ti64. As a result, Amaero has met the powder qualification condition set by advanced 3D printing company Velo3D - clearing the way for initial commercial orders. Velo3D has now placed…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.